Respiratory Syncytial Virus Immune Globulin Dosage
Applies to the following strengths: 50 mg/mL
Usual Pediatric Dose for:
Additional dosage information:
Usual Pediatric Dose for Respiratory Syncytial Virus
< 24 months: 750 mg/kg/month during the RSV season. The typical RSV season is November through April but regional differences may exist.
The infusion should be gradually increased as tolerated by starting with 1.5 mL/kg/hr for 15 minutes followed by 3.6 mL/kg/hr for remainder of infusion. Rate of infusion should not exceed 3.6 mL/kg/hr. It may be necessary to infuse at a slower rate in some patients, especially ill children with BPD.
Renal Dose Adjustments
There are no data on exact dose adjustments in patients with renal dysfunction. However, renal dysfunction including acute renal failure and osmotic nephrosis, some resulting in death, have been reported in association with immune globulin intravenous (human) products. The incidence may be related to the rate of infusion, product concentration, the presence of sucrose as a stabilizer, or patient characteristics predisposing to acute renal failure.
Liver Dose Adjustments
Data not available
Precautions
Use caution to avoid fluid accumulation when administering RSV-IGIV to patients with underlying pulmonary disease.
Watch for signs of hypersensitivity when administering RSV-IGIV.
Live virus vaccines, including MMR and varicella, should be deferred for 9 months after administration of RSV-IGIV.
Dialysis
Data not available
Other Comments
Vital signs and cardiopulmonary status should be assessed prior to infusion, before each rate increase, and at 30-minute intervals until 30 minutes after infusion.
RSV-IGIV contains sucrose.
More about respiratory syncytial virus immune globulin
Patient resources
Other brands
Related treatment guides
See also:
Arexvy
Arexvy is an RSV vaccine used to prevent severe Respiratory Syncytial Virus Vaccine (RSV) symptoms ...
Abrysvo
Abrysvo vaccine protects against LRTD (lower respiratory tract disease) caused by the Respiratory ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Beyfortus
Beyfortus is used to protect babies under 1 year of age from serious RSV lung infections. A ...
Synagis
Synagis is used to prevent lung disease caused by respiratory syncytial virus. Learn about side ...
mRESVIA
mResvia is an RSV vaccine that may be used to protect adults aged 60 years and older against lower ...
Palivizumab
Palivizumab systemic is used for RSV, RSV Vaccination and Immunization
Nirsevimab
Nirsevimab information from Drugs.com, includes Nirsevimab side effects, interactions and indications.
Rsv vaccine, mrna
Rsv vaccine, mrna systemic is used for RSV, RSV Vaccination and Immunization
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.